TECHNICAL INFORMATION RESEARCH RESOURCES FOR CANCER PREVENTIVE AGENT DEVELOPMENT

癌症预防剂开发的技术信息研究资源

• 批准号: 8737158
• 负责人: CAROLINE C SIGMAN
• 金额: $ 187.84万
• 依托单位: CCS ASSOCIATES, INC.
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-30 至 2014-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8737158
• 关键词: Agreement; Biological Products; Chemical Agents; Clinical; Clinical Trials; Confidentiality; Contracts; Data Reporting; Databases; Development; Documentation; Genomics; Industry; Information Management; Investigational New Drug Application; Literature; Malignant Neoplasms; Management Information Systems; Manuscripts; Medical; Office of Administrative Management; Pharmacologic Substance; Prevention Research; Preventive; Proteomics; Reporting; Research; Resources; Structure; abstracting; cancer prevention; meetings; pre-clinical; programs; research and development; technical report

The purpose of the contract is to provide a variety of critical cancer prevention research information management functions necessary to support the identification, development, and qualification of potential cancer preventive agents for investigational new drug (IND) applications to the FDA for clinical trials. Support for cancer preventive agent development includes the gathering and organizing of information from the research, pharmaceutical, and medical literature; preclinical and clinical technical project reports; scientific meetings; and private industry documents provided to the NCI under confidentiality agreements. Support also includes abstracting and maintaining data bases of technical reports; abstracting application materials for the PREVENT Cancer Program; preparing specific chemical and biological agent and general class documents and structure / function and genomic / proteomic informational and statistical analyses for the Management Administrative Committee (MAC); and drafting minutes of the External Steering Panel, the Special Emphasis Panel and MAC meetings and manuscripts of current topics, progress, and opportunities in cancer preventive agent development research.

该合同的目的是提供各种关键的癌症预防研究信息管理功能，以支持对临床试验的FDA进行研究的癌症预防剂（IND）申请的鉴定，开发和资格。对癌症预防剂开发的支持包括从研究，药物和医学文献中收集和组织信息；临床前和临床技术项目报告；科学会议；以及根据机密协议提供给NCI的私人行业文件。支持还包括抽象和维护技术报告的数据库；为预防癌症计划抽象应用材料；为管理行政委员会（MAC）准备特定的化学和生物剂以及一般类文档以及结构 /功能以及基因组 /蛋白质组学信息和统计分析；并起草了外部转向面板，特别重点小组以及MAC会议以及当前主题，进度和癌症预防剂开发研究机遇的手稿。